As the global economy mends, the 2021 growth of Adrenocortical Hormones API will have significant change from previous year. According to our (LP Information) latest study, the global Adrenocortical Hormones API market size is USD million in 2022 from USD 2061.5 million in 2021, with a change of % between 2021 and 2022. The global Adrenocortical Hormones API market size will reach USD 3232.9 million in 2028, growing at a CAGR of 6.6% over the analysis period.
The United States Adrenocortical Hormones API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Adrenocortical Hormones API market, reaching US$ million by the year 2028. As for the Europe Adrenocortical Hormones API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Adrenocortical Hormones API players cover Pfizer CentreOne, Sanofi, GlaxoSmithKline, and Tianjin Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Adrenocortical Hormones API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Prednisone Series
Dexamethasone Series
Betamethasone Series
Hydrocortisone Series
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Injectable Drugs
Oral Drugs
For External Use Drugs
Inhalation Drugs
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer CentreOne
Sanofi
GlaxoSmithKline
Tianjin Pharmaceutical Group Co., Ltd.
Xianju Pharma
Guangdong VTR Bio-Tech Co., Ltd
Symbiotec Pharmalab
Sun Pharmaceutical
Cipla
Hovione
Shandong Xinhua Pharmaceutical Company Limited
Steroid SpA
Junye Pharmaceutical Co., Ltd.
Avik Pharmaceutical
Great Pacific Exports
Shanghai New Hualian Pharmaceutical Co., Ltd
Shandong Taihua Bio & Tech Stock Co., Ltd
Tianjin Pacific Pharmaceutical Co., Ltd (TJPP)
Teva
Zhejiang Xianju Xianle Pharmaceutical Co., Ltd.
Jiangsu Lianhuan Pharmaceutical Co., Ltd
Shandong Sito Bio-technology CO., LTD